Glancy Prongay & Murray LLP Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors


GPM is preparing a lawsuit on behalf of Sinovac investors. Sinovac is a biopharmaceutical company that engages in the research, development, manufacture and commercialization of vaccines against hepatitis A, hepatitis B, seasonal influenza, H5N1 and H1N1 pandemic influenza and mumps in the People's Republic of China.



from Biotech News